Stock PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.47 USD +6.52% Intraday chart for Pacific Biosciences of California, Inc. -5.16% -85.02%
Apr. 22 JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight MT
Apr. 18 Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. PACB Stock
  4. Revisions Pacific Biosciences of California, Inc.